Question 1

Has Danny Woo received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $427,051 in general payments to Danny Woo across 722 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Danny Woo did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Danny Woo come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Otsuka America Pharmaceutical, Inc.	270	$253,965
AstraZeneca(2 entities)	253	$164,810
Amgen(2 entities)	48	$1,487
Johnson & Johnson	9	$818
Novartis	9	$711
GSK	7	$587
Vifor Pharma, Inc.	31	$547
Novo Nordisk	4	$388
Organogenesis Inc.	3	$330
Bayer	7	$310
Esperion Therapeutics, Inc.	3	$305
Fresenius USA Marketing, Inc.	16	$286
Phathom Pharmaceuticals, Inc.	2	$196
AbbVie	2	$189
Akebia Therapeutics Inc	10	$162
Mallinckrodt Hospital Products Inc.	5	$138
Medtronic	1	$127
Pfizer	1	$120
Amarin Pharma, Inc.	1	$120
E.r. Squibb & Sons, L.L.C.	1	$119
Lucid Diagnostics Inc.	1	$117
Biohaven Pharmaceuticals, Inc.	1	$116
OPKO Pharmaceuticals, LLC	8	$113
Mallinckrodt Enterprises LLC	8	$111
Clarus Therapeutics Inc.	1	$110
Lexicon Pharmaceuticals, Inc.	1	$105
Axsome Therapeutics, Inc.	1	$104
Merck	1	$101
Sanofi-aventis U.S. LLC	1	$96
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$87
Lilly USA, LLC	1	$81
Otsuka Pharmaceutical Development & Commercialization, Inc.	3	$57
Daiichi Sankyo Inc.	3	$45
Genentech USA, Inc.	2	$25
Shire North American Group Inc	2	$23
Lundbeck LLC	1	$13
Leadiant Biosciences, Inc.	1	$13
Ultragenyx Pharmaceutical Inc.	1	$11
Takeda Pharmaceuticals U.S.A., Inc.	1	$11

Danny Woo

Payments from drug & device makers

Who reported the general payments

How this compares

Other nephrology in Louisville